An Australian woman who took Ozempic to lose weight before her daughter’s wedding has died of a gastrointestinal illness — now her husband is warning the drug is “absolutely not worth it.”
Trish Webster, 56, was given Ozempic to help her wear her dream dress for her daughter’s wedding.
Ozempic is a drug approved by the US Food and Drug Administration for people with Type 2 diabetes — it has been widely used as a weight loss drug around the world.
The drug works by mimicking a natural hormone, GLP-1, which slows the passage of food through the stomach and intestines, making people feel fuller for longer.
Problems arise if the medicine slows down the stomach too much or blocks the intestines.
An Australian woman who took Ozempic to lose weight before her daughter’s wedding has died of a gastrointestinal illness — now her husband is warning the drug is “absolutely not worth it.” 60 Minutes Australia “She had a little chocolate stuff coming out of her mouth, and I realized he wasn’t breathing and started doing CPR,” said Roy Webster.60 Minutes Australia
Intestinal obstruction is called “ileus” — the FDA received 18 reports of it in people taking Ozempic in late September.
For his part, Webster took Ozempic along with a prescription injection of Saxenda, losing about 35 pounds over five months, according to local media reports.
Although the drugs helped Webster lose weight quickly, they reportedly made him sick.
On January 16, just months before her daughter’s wedding, Webster’s husband allegedly found her unconscious with brown liquid seeping from her mouth.
“He had some brown stuff coming out of his mouth, and I realized he wasn’t breathing and started doing CPR,” Roy Webster told “60 Minutes Australia” last week.
“It was just pouring, and I turned him to the side because he couldn’t breathe.”
Trish Webster, 56, was given Ozempic to help her wear her dream dress for her daughter’s wedding. 60 Minutes Australia On January 16, just months before his daughter’s wedding, Webster’s husband allegedly found her unconscious with brown liquid seeping from her mouth. 60 Minutes Australia
Webster died that night, with the cause of death listed as acute gastrointestinal disease.
“If I had known that could happen, he wouldn’t have taken it,” insisted the grieving husband. “I never thought you could die from it.”
Although Webster’s death was not officially linked to the use of Ozempic and Saxenda, her husband blamed the drugs.
“He shouldn’t have gone, you know,” Roy said. “It’s not worth it, it’s not worth it at all.”
In a statement to “60 Minutes Australia,” Ozempic’s manufacturer, Novo Nordisk, said ileus was only reported after its “post-marketing setting,” suggesting the drugmaker only became aware of the problem after the drug was released.
“He shouldn’t have gone, you know,” Roy said. “It’s not worth it, it’s not worth it at all.”60 Minutes Australia
Novo Nordisk and Eli Lilly and Company, which manufactures Mounjaro, are being sued in the US over allegations that their popular weight loss drug can cause severe gastrointestinal problems, such as gastroparesis or “stomach paralysis,” which can lead to death.
Law firm Morgan & Morgan told The Post in August that it had received 500 similar inquiries from clients in 45 states, along with claims of injuries allegedly caused by other weight-loss drugs, including Wegovy, Rybelsus and Saxenda.
A representative for Novo Nordisk told The Post at the time, “Semaglutide has been extensively examined in robust clinical development programs, large real-world evidence studies and cumulatively more than 9.5 million years of patient exposure.”
The company states that “gastrointestinal (GI) events are a well-known side effect of the GLP-1 class.”
“Patient safety is Lilly’s top priority, and we are actively involved in monitoring, evaluating and reporting safety information for all of our drugs,” Lilly told The Post in a statement.
The FDA in September updated Ozempic’s label to acknowledge complaints of bowel obstruction in some people who have taken the drug. 60 Minutes Australia
The FDA in September updated Ozempic’s label to acknowledge complaints of intestinal blockage in some people who have taken the drug.
The update comes after the federal agency received thousands of reports of gastrointestinal problems from Ozempic users.
Gastroparesis is just one of many side effects that have been reported, including “Ozempic Fingers,” “Ozempic Burps,” “Ozempic Backs,” “Ozempic Faces” and strange dreams about celebrities.
Some experts have warned that Ozempic and similar drugs have not been available long enough to study long-term effects — including suicidal concerns — and may be abused by some people as a quick way to shed a few pounds.
Categories: Trending
Source: thtrangdai.edu.vn/en/
